| Literature DB >> 30178770 |
Taiga Wakabayashi1, Yuta Abe1, Osamu Itano2, Masahiro Shinoda1, Minoru Kitago1, Hiroshi Yagi1, Taizo Hibi3, Go Oshima1, Takuya Minagawa1, Yuko Kitagawa1.
Abstract
BACKGROUND: Technological innovations have made it possible to use laparoscopic liver resection in cases with pre-existing adhesions or cicatricial changes. However, laparoscopic repeat liver resection (LRLR) still represents a challenge for surgeons, especially in case of previous open liver surgery. This study evaluated the outcomes of LRLR after open liver resection (OLR) in cases of recurrent liver cancer.Entities:
Keywords: Difficulty score; laparoscopic; minor liver resection; previous open liver resection; repeat liver resection; short-term outcomes
Year: 2020 PMID: 30178770 PMCID: PMC6945330 DOI: 10.4103/jmas.JMAS_175_18
Source DB: PubMed Journal: J Minim Access Surg ISSN: 1998-3921 Impact factor: 1.407
Patient demographics
| LRLR group ( | LPLR group ( | ||
|---|---|---|---|
| Basic characteristics | |||
| Age (years) | 70 (54-88) | 72 (45-87) | 0.839 |
| Sex, male | 11 (85) | 35 (71) | 0.334 |
| Primary histology | 0.702 | ||
| HCC | 10 (77) | 40 (82) | |
| CRLM | 3 (23) | 9 (18) | |
| Hepatitis background | 0.036* | ||
| HBV | 5 (38) | 5 (10) | |
| HCV | 4 (31) | 15 (31) | |
| Neither | 4 (31) | 29 (59) | |
| Body mass index, kg/m2 | 24 (17-27) | 24 (16-40) | 0.209 |
| Liver function | |||
| Child-Pugh score | 0.459 | ||
| A | 13 (100) | 47 (96) | |
| B | 0 | 2 (4) | |
| ICG15R, % | 9.4 (2.8-27.1) | 14.1 (2.7-81.5) | 0.085 |
| Liver cirrhosis | 3 (23) | 17 (35) | 0.426 |
| Previous abdominal surgery | |||
| Cases | 4 (31) | 16 (33) | 0.897 |
| Surgeries | 5 | 18 | |
| Recurrence of liver cancer | 13 (100) | 11 (22) | <0.001* |
Values are reported as median (range) or number (%). *Indicates a significant difference (P<0.05). LRLR: Laparoscopic repeat liver resection, LPLR: Laparoscopic primary liver resection, HCC: Hepatocellular carcinoma, CRLM: Colorectal liver metastasis, HBV: Hepatitis B virus, HCV: Hepatitis C virus, ICG15R: Indocyanine green retention at 15 min
Surgical characteristics
| LRLR group ( | LPLR group ( | ||
|---|---|---|---|
| Extent of resection | |||
| Left lateral sectionectomy | 1 (8) | 2 (4) | 0.590 |
| Partial | 12 (92) | 47 (96) | |
| Techniques | |||
| Purely laparoscopic | 11 (85) | 48 (98) | 0.109 |
| Laparoscopy-assisted | 2 (15) | 1 (2) | |
| Pringle manoeuvre | 7 (54) | 27 (55) | 0.936 |
| Difficulty score | |||
| Low | 5 (38) | 25 (51) | 0.483 |
| Intermediate | 7 (54) | 23 (47) | |
| High | 1 (8) | 1 (2) |
Values are reported as number of patients (%).LRLR: Laparoscopic repeat liver resection, LPLR: Laparoscopic primary liver resection
Details of the laparoscopic repeat liver resection cases
| Case | Sex | Age | Primary histology | PLR procedure | Tumour location in PLR | Previous liver therapy | Surgery interval (months) | LRLR procedure | LA | Post-operative complication | Difficulty | Operative time (min) | Blood loss (g) | Hospital stay (days) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Male | 70 | HCC | ex. RPS | S6/7 | 3 × Cryo, MCT, RFA | 13 | S5 par | P | I | 333 | 350 | 11 | |
| 2 | Male | 62 | HCC | par | S5/6 | - | 17 | S3, S5 par | P | L | 297 | 350 | 10 | |
| 3 | Male | 54 | HCC | LLS | S2/3 | - | 72 | S4 par | P | L | 396 | 200 | 11 | |
| 4 | Female | 80 | HCC | par | S4/5 | RFA | 54 | LLS | P | Bile leak | I | 389 | 100 | 24 |
| 5 | Male | 60 | HCC | par | S8 | - | 24 | S2 par | P | L | 212 | 5 | 7 | |
| 6 | Male | 70 | CRLM | par | S4/8 | - | 49 | S4 par | P | L | 276 | 5 | 8 | |
| 7 | Male | 69 | HCC | par and ex. RPS | S1, S5/6 | TACE, MCT, RFA | 24 | S4 par | P | L | 377 | 50 | 6 | |
| 8 | Male | 88 | CRLM | par | S5/6, S8 | - | 37 | S8 par | H | I | 480 | 350 | 46 | |
| 9 | Female | 70 | HCC | LH | S2/3 | PEIT, TACE, 2 × RFA | 66 | S5 par | P | L | 317 | 0 | 7 | |
| 10 | Male | 78 | HCC | par | S1 | PEIT, TACE, RFA | 39 | S4/8 par | H | Bile leak | I | 556 | 870 | 40 |
| 11 | Male | 65 | HCC | ex. RPS | S6/7, S5/8 | - | 95 | S3/4, S5 par | P | I | 553 | 650 | 8 | |
| 12 | Male | 72 | HCC | par | S2, S4 | TACE, RFA | 129 | S3/4 par | P | H | 346 | 100 | 19 | |
| 13 | Male | 65 | CRLM | ex. RPS | S5/6 | 18 | S8 par | P | I | 278 | 10 | 9 |
HCC: Hepatocellular carcinoma, CRLM: Colorectal Liver Metastasis, PLR: Previous liver resection, Ex. RPS: Extended Right Posterior Sectionectomy, Par: Partial resection, LLS: Left Lateral Sectionectomy, LH: Left Haemihepatectomy, Cryo: Cryoablation, MCT: Microwave Coagulation Therapy, RFA: Radiofrequency ablation, TACE: Transcatheter Arterial Chemoembolisation, PEIT: Percutaneous Ethanol Injection Therapy, LRLR: Laparoscopic Repeat Liver Resection, LA: Laparoscopic approach (H: Hybrid, P: Purely Laparoscopic Resection), I: Intermediate, L: Low, H: High
Short-term surgical outcomes
| All cases | LRLR ( | LPLR ( | |
|---|---|---|---|
| Operative time (min) | 346 (212-556) | 297 (84-831) | 0.712 |
| Estimated blood loss (g) | 100 (0-870) | 150 (0-2400) | 0.611 |
| Transfusion requirement | 1 (8) | 7 (14) | 1.000 |
| Conversion to laparotomy (%) | 0 | 0 | NA |
| Complications (≥ CDIIIa) | 2 (15) | 5 (10) | 0.630 |
| Complications (< CDIIIa) | 0 | 5 (10) | 0.574 |
| Positive surgical margin | 2 (15) | 10 (20) | 0.684 |
| Time to oral intake (days) | 2 (2-4) | 2 (1-12) | 0.814 |
| Hospital stay (days) | 10 (6-46) | 9 (5-50) | 0.351 |
| Operative time (min) | 297 (212-396) | 282 (84-641) | 0.852 |
| Estimated blood loss (g) | 50 (5-350) | 50 (0-2400) | 0.603 |
| Transfusion requirement | 0 | 3 (6) | 1.000 |
| Conversion to laparotomy (%) | 0 | 0 | NA |
| Complications (≥CDIIIa) | 0 | 1 (2) | 1.000 |
| Complications (<CDIIIa) | 0 | 2 (4) | 1.000 |
| Positive surgical margin | 1 (8) | 4 (8) | 1.000 |
| Time to oral intake (days) | 2 (2-2) | 2 (1-5) | 0.753 |
| Hospital stay (days) | 8 (6-11) | 8 (5-16) | 0.760 |
| Operative time (min) | 389 (278-556) | 416 (202-831) | 0.868 |
| Estimated blood loss (g) | 350 (0-870) | 200 (0-2250) | 0.861 |
| Transfusion requirement | 1 (7) | 3 (6) | 1.000 |
| Conversion to laparotomy (%) | 0 | 0 | NA |
| Complications (≥CDIIIa) | 2 (14) | 3 (6) | 0.565 |
| Complications (<CDIIIa) | 0 | 3 (6) | 1.000 |
| Positive surgical margin | 1 (7) | 6 (12) | 1.000 |
| Time to oral intake (days) | 3 (2-4) | 3 (1-12) | 0.864 |
| Hospital stay (days) | 11 (7-46) | 12 (6-50) | 0.264 |
Values are reported as median (range) or n (%). NA: Not available
Figure 1Recurrence-free survival, procedure-related survival and overall survival among cases with hepatocellular carcinoma. Among cases with hepatocellular carcinoma, no significant differences between the two groups were observed for (a) recurrence-free survival (P = 0.118) or (b) procedure-related survival (P = 0.659) and (c) overall survival (P = 0.693)